Dear CONN community,
I am working with a within-patient cross-over design and would appreciate your thoughts on my strategy to analyse functional connectivity in CONN.
Design
Each participant underwent 4 resting-state fMRI sessions:
Baseline
Treatment or placebo phase
Baseline (after wash-out)
The alternate phase (placebo or treatment)
The order of treatment/placebo was counterbalanced.
Goal
Previous work shows a robust treatment effect on functional
connectivity (FC) in two predefined networks
(seed-based).
I would like to test:
within-subject effects of treatment vs. placebo
patient-level effects (between-subject variability)
Because CONN currently does not implement mixed-effects linear
models across multiple sessions, my idea was to:
Compute FC in the predefined networks and set up a contrast that averages the effect across all four sessions (e.g. baseline, treatment/placebo, baseline, treatment/placebo weighted 1/4 each).
Extract the resulting subject-level FC values.
Run a mixed-effects model in R, using participant ID and timepoint as random factors and treatment as the fixed effect.
Would you consider this a valid workflow, or would you recommend a different modelling strategy within CONN (e.g. a different second-level design or custom contrasts) before exporting the data?
Many thanks in advance.
Best regards,
Vanessa